Inventor
CUI DAWEI
CN18 patents
⚠️ This page may combine multiple inventors who share the name “CUI DAWEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AGIOS PHARMACEUTICALS INC
13 patentsUS9474779B2Oct 25, 2016
Therapeutically active compositions and their methods of use
AGIOS PHARMACEUTICALS INC36 citations97
US9850277B2Dec 26, 2017
Therapeutically active compositions and their methods of use
AGIOS PHARMACEUTICALS INC22 citations93
US11364240B2Jun 21, 2022
Pyruvate kinase activators for use in treating blood disorders
AGIOS PHARMACEUTICALS INC4 citations83
US11040036B2Jun 22, 2021
Pyruvate kinase activators for use in treating blood disorders
AGIOS PHARMACEUTICALS INC7 citations83
US11590132B2Feb 28, 2023
Pyruvate kinase activators for use in treating blood disorders
AGIOS PHARMACEUTICALS INC1 citations72
US10717764B2Jul 21, 2020
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC1 citations72
US10640534B2May 5, 2020
Therapeutically active compositions and their methods of use
AGIOS PHARMACEUTICALS INC2 citations72
US11464775B2Oct 11, 2022
Pyruvate kinase modulators and use thereof
AGIOS PHARMACEUTICALS INC3 citations71
US12133853B2Nov 5, 2024
Pyruvate kinase activators for use in treating blood disorders
AGIOS PHARMACEUTICALS INC0 citations62
US11957680B2Apr 16, 2024
Pyruvate kinase activators for use in treating blood disorders
AGIOS PHARMACEUTICALS INC0 citations62
US11021515B2Jun 1, 2021
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC0 citations62
US11872225B2Jan 16, 2024
Pyruvate kinase modulators and use thereof
AGIOS PHARMACEUTICALS INC0 citations61
US10689414B2Jun 23, 2020
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC0 citations51